Part D Claims Data Sharing: Lack Of Progress Gets MedPAC’s Attention
Medicare advisory panel is considering a recommendation for congressional action to spur availability of Medicare drug data for policy and safety research.
Medicare advisory panel is considering a recommendation for congressional action to spur availability of Medicare drug data for policy and safety research.